Company profile for Invex Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on developing treatments for neurological disorders associated with raised intracranial pressure (ICP), such as idiopathic intracranial hypertension, traumatic brain injury, and acute stroke. The company?s lead program involves the repurposing of the approved drug Exenatide, branded by Invex as Presendin?, to target and lower ICP?addressing a significant unme...
Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on developing treatments for neurological disorders associated with raised intracranial pressure (ICP), such as idiopathic intracranial hypertension, traumatic brain injury, and acute stroke. The company?s lead program involves the repurposing of the approved drug Exenatide, branded by Invex as Presendin?, to target and lower ICP?addressing a significant unmet medical need. Headquartered in Perth, Australia, Invex is committed to advancing research that enhances brain pressure regulation and delivers impactful neurological therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
c/- Automic GroupLevel 5, 191 St Georges TerracePerth WA 6000
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty